Kardiovaskulære risici ved behandling med nonsteroide antiinflammatoriske lægemidler

Morten Schmidt; Emil Loldrup Fosbøl; Christian Torp-Pedersen; Anne-Marie Schjerning Olsen; bo Christensen; Gunnar H Gislason

Kardiovaskulære risici ved behandling med nonsteroide antiinflammatoriske lægemidler

Morten Schmidt, Emil Loldrup Fosbøl, Christian Torp-Pedersen, Anne-Marie Schjerning Olsen, bo Christensen, Gunnar H Gislason

Hjertesygdomme

Abstract

Non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used drugs. Current evidence supports that all NSAIDs increase the risk of heart failure and elevate blood pressure, whereas the risk of thrombotic events varies with the type of drug. Use of newer selective cyclooxygenase-2 inhibitors has been associated with a substantial vascular risk but increasing concern also relates to traditional NSAIDs, in particular diclofenac. This review summarizes the current evidence regarding the cardiovascular safety of NSAIDs and presents recommendations for their use.

Bidragets oversatte titel	Cardiovascular risks of non-steroidal anti-inflammatory drugs treatment
Originalsprog	Dansk
Artikelnummer	V08160612
Tidsskrift	Ugerskrift for Læger
Vol/bind	178
Udgave nummer	52
Sider (fra-til)	V08160612
ISSN	1603-6824
Status	Udgivet - 26 dec. 2016

Emneord

karsygdomme
non-steroide anti-inflammatoriske lægemidler
hjertesygdomme
risikovurdering

Adgang til dokumentet

http://ugeskriftet.dk/videnskab/kardiovaskulaere-risici-ved-behandling-med-nonsteroide-antiinflammatoriske-laegemidler

Citationsformater

Schmidt, M., Fosbøl, E. L., Torp-Pedersen, C., Schjerning Olsen, A.-M., Christensen, B., & Gislason, G. H. (2016). Kardiovaskulære risici ved behandling med nonsteroide antiinflammatoriske lægemidler. Ugerskrift for Læger, 178(52), V08160612. Artikel V08160612. http://ugeskriftet.dk/videnskab/kardiovaskulaere-risici-ved-behandling-med-nonsteroide-antiinflammatoriske-laegemidler

Schmidt, M, Fosbøl, EL , Torp-Pedersen, C , Schjerning Olsen, A-M, Christensen, B & Gislason, GH 2016, 'Kardiovaskulære risici ved behandling med nonsteroide antiinflammatoriske lægemidler', Ugerskrift for Læger, bind 178, nr. 52, V08160612, s. V08160612. <http://ugeskriftet.dk/videnskab/kardiovaskulaere-risici-ved-behandling-med-nonsteroide-antiinflammatoriske-laegemidler>

@article{8f0f3ce53ce442289585173f78e23ae3,

title = "Kardiovaskul{\ae}re risici ved behandling med nonsteroide antiinflammatoriske l{\ae}gemidler",

abstract = "Non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used drugs. Current evidence supports that all NSAIDs increase the risk of heart failure and elevate blood pressure, whereas the risk of thrombotic events varies with the type of drug. Use of newer selective cyclooxygenase-2 inhibitors has been associated with a substantial vascular risk but increasing concern also relates to traditional NSAIDs, in particular diclofenac. This review summarizes the current evidence regarding the cardiovascular safety of NSAIDs and presents recommendations for their use.",

keywords = "karsygdomme, non-steroide anti-inflammatoriske l{\ae}gemidler, hjertesygdomme, risikovurdering",

author = "Morten Schmidt and Fosb{\o}l, {Emil Loldrup} and Christian Torp-Pedersen and {Schjerning Olsen}, Anne-Marie and bo Christensen and Gislason, {Gunnar H}",

note = "Med litteraturhenvisninger",

year = "2016",

month = dec,

day = "26",

language = "Dansk",

volume = "178",

pages = "V08160612",

journal = "Ugerskrift for L{\ae}ger",

issn = "1603-6824",

publisher = "Almindelige Danske Laegeforening",

number = "52",

}

TY - JOUR

T1 - Kardiovaskulære risici ved behandling med nonsteroide antiinflammatoriske lægemidler

AU - Schmidt, Morten

AU - Fosbøl, Emil Loldrup

AU - Torp-Pedersen, Christian

AU - Schjerning Olsen, Anne-Marie

AU - Christensen, bo

AU - Gislason, Gunnar H

N1 - Med litteraturhenvisninger

PY - 2016/12/26

Y1 - 2016/12/26

N2 - Non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used drugs. Current evidence supports that all NSAIDs increase the risk of heart failure and elevate blood pressure, whereas the risk of thrombotic events varies with the type of drug. Use of newer selective cyclooxygenase-2 inhibitors has been associated with a substantial vascular risk but increasing concern also relates to traditional NSAIDs, in particular diclofenac. This review summarizes the current evidence regarding the cardiovascular safety of NSAIDs and presents recommendations for their use.

AB - Non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used drugs. Current evidence supports that all NSAIDs increase the risk of heart failure and elevate blood pressure, whereas the risk of thrombotic events varies with the type of drug. Use of newer selective cyclooxygenase-2 inhibitors has been associated with a substantial vascular risk but increasing concern also relates to traditional NSAIDs, in particular diclofenac. This review summarizes the current evidence regarding the cardiovascular safety of NSAIDs and presents recommendations for their use.

KW - karsygdomme

KW - non-steroide anti-inflammatoriske lægemidler

KW - hjertesygdomme

KW - risikovurdering

M3 - Tidsskriftartikel

C2 - 28041549

SN - 1603-6824

VL - 178

SP - V08160612

JO - Ugerskrift for Læger

JF - Ugerskrift for Læger

IS - 52

M1 - V08160612

ER -

Kardiovaskulære risici ved behandling med nonsteroide antiinflammatoriske lægemidler

Abstract

Emneord

Adgang til dokumentet

Fingeraftryk

Citationsformater